Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhe Sang

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Biorxiv : the Preprint Server for Biology|August 10, 2021
<i>Llamanade</i> : an open-source computational pipeline for robust nanobody humanizationZhe Sang, Yufei Xiang, Ivet Bahar, et al.
Structure (London, England : 1993)|December 13, 2021
Llamanade: An open-source computational pipeline for robust nanobody humanizationZhe Sang, Yufei Xiang, Ivet Bahar, et al.
Advanced Drug Delivery Reviews|February 8, 2023
Nanobodies: Robust miniprotein binders in biomedicineJeffrey Yong Joon Kim, Zhe Sang, Yufei Xiang, et al.
Cell Systems|February 16, 2021
Integrative proteomics identifies thousands of distinct, multi-epitope, and high-affinity nanobodiesYufei Xiang, Zhe Sang, Lirane Bitton, et al.
Cell Systems|November 22, 2025
One thousand SARS-CoV-2 antibody structures reveal convergent binding and near-universal immune escapeZirui Feng, Zhe Sang, Yufei Xiang, et al.
Science (New York, N.Y.)|November 6, 2020
Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2Yufei Xiang, Sham Nambulli, Zhengyun Xiao, et al.
Biorxiv : the Preprint Server for Biology|September 2, 2020
Versatile, Multivalent Nanobody Cocktails Efficiently Neutralize SARS-CoV-2Yufei Xiang, Sham Nambulli, Zhengyun Xiao, et al.
Science Advances|April 24, 2026
Repertoire-scale antibody structural prediction informs therapeutic designZhe Sang, Yufei Xiang, Wei Huang, et al.
Nature Communications|August 1, 2018
Operando and three-dimensional visualization of anion depletion and lithium growth by stimulated Raman scattering microscopyQian Cheng, Lu Wei, Zhe Liu, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2021
Inhalable Nanobody (PiN-21) prevents and treats SARS-CoV-2 infections in Syrian hamsters at ultra-low dosesSham Nambulli, Yufei Xiang, Natasha L Tilston-Lunel, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Biorxiv : the Preprint Server for Biology|August 10, 2021
<i>Llamanade</i> : an open-source computational pipeline for robust nanobody humanizationZhe Sang, Yufei Xiang, Ivet Bahar, et al.
Structure (London, England : 1993)|December 13, 2021
Llamanade: An open-source computational pipeline for robust nanobody humanizationZhe Sang, Yufei Xiang, Ivet Bahar, et al.
Advanced Drug Delivery Reviews|February 8, 2023
Nanobodies: Robust miniprotein binders in biomedicineJeffrey Yong Joon Kim, Zhe Sang, Yufei Xiang, et al.
Cell Systems|February 16, 2021
Integrative proteomics identifies thousands of distinct, multi-epitope, and high-affinity nanobodiesYufei Xiang, Zhe Sang, Lirane Bitton, et al.
Cell Systems|November 22, 2025
One thousand SARS-CoV-2 antibody structures reveal convergent binding and near-universal immune escapeZirui Feng, Zhe Sang, Yufei Xiang, et al.
Science (New York, N.Y.)|November 6, 2020
Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2Yufei Xiang, Sham Nambulli, Zhengyun Xiao, et al.
Biorxiv : the Preprint Server for Biology|September 2, 2020
Versatile, Multivalent Nanobody Cocktails Efficiently Neutralize SARS-CoV-2Yufei Xiang, Sham Nambulli, Zhengyun Xiao, et al.
Science Advances|April 24, 2026
Repertoire-scale antibody structural prediction informs therapeutic designZhe Sang, Yufei Xiang, Wei Huang, et al.
Nature Communications|August 1, 2018
Operando and three-dimensional visualization of anion depletion and lithium growth by stimulated Raman scattering microscopyQian Cheng, Lu Wei, Zhe Liu, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2021
Inhalable Nanobody (PiN-21) prevents and treats SARS-CoV-2 infections in Syrian hamsters at ultra-low dosesSham Nambulli, Yufei Xiang, Natasha L Tilston-Lunel, et al.
Pageof 2